Clinical significance of determining neutrophil extracellular traps in women with oncogynecological neoplasms

The formation of neutrophil extracellular traps (NETs), described first in 2004 as a previously unknown neutrophil strategy for combating microbes, has been attracting a growing interest in research community. NETs play a key role in inflammation and infection exploiting effector functions such as degranulation, phagocytosis as well as production of reactive oxygen species (ROS). NETs play a crucial role in defense against systemic infections. Additionally NETs involved in inflammation, and in the pathogenesis of non-infectious diseases, such as autoimmune diseases and cancer.

1. Beiter T., Fragasso A., HartlD., Nieß A.M. Neutrophil extracellular traps: a walk on the wild side of exercise immunology. Sports Med. 2015;45(5):625–40. https://doi.org/10.1007/s40279-014-0296-1.

2. Finazzi G. The Italian Registry of antiphospholipid antibodies. Haematologica. 1997;82(1):101–5.

3. Saffarzadeh M., Juenemann C., Queisser M.A. et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PloS One. 2012;7(2):e32366. https://doi.org/10.1371/journal.pone.0032366.

4. Fine N., Tasevski N., McCulloch C.A. et al. The neutrophil: constant defender and first responder. Front Immunol. 2020;11:571085. https://doi.org/10.3389/fimmu.2020.571085.

5. Vilen S.-T., Nyberg P., Hukkanen M. et al. Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma. Exp Cell Res. 2008;314(4):914–26. https://doi.org/10.1016/j.yexcr.2007.10.025.

6. Antoneeva I.I. Oxygen-dependent antimicrobial system of neutrophils in the dynamics of ovarian cancer. [Kislorodzavisimaya antimikrobnaya sistema nejtrofilov v dinamike razvitiya raka yaichnikov]. Kazanskij medicinskij zhurnal. 2008;89(4):476–8. (In Russ.).

7. Schauer C., Janko C., Munoz L.E. et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med. 2014;20(5):511–7. https://doi.org/10.1038/nm.3547.

8. Shi X., Li B., Yuan Y. et al. The possible association between the presence of an MPO -463 G > A (rs2333227) polymorphism and cervical cancer risk. Pathol Res Pract. 2018;8(214):1142–8. https://doi.org/10.1016/j.prp.2018.05.018.

9. Falanga A., Rickles F.R. Pathophysiology of the thrombophilic state in the cancer patient. Semin Thromb Hemost. 1999;25(2):173–82. https://doi.org/10.1016/10.1055/s-2007-994919.

10. Fine N., Tasevski N., McCulloch C.A. et al. The neutrophil: constant defender and first responder. Front Immunol. 2020;11:571085. https://doi.org/10.1016/10.3389/fimmu.2020.571085.

11. Brinkmann V., Reichard U., Goosmann C. et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532–5. https://doi.org/10.1126/science.1092385.

12. Arazna M., Pruchniak M.P., Zycinska K., Demkow U. Neutrophil extracellular trap in human diseases. Adv Exp Med Biol. 2013;756:1–8. https://doi.org/10.1007/978-94-007-4549-0_1.

13. Yalavarthi S., Gould T.J., Rao A.N. et al. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome. Arthritis Rheumatol. 2015;67(11):2990–3003. https://doi.org/10.1002/art.39247.

14. Demers M., Wagner D.D. NETosis: a new factor in tumor progression and cancer-associated thrombosis. Semin Thromb Hemost. 2014;40(3):277–83. https://doi.org/10.1055/s-0034-1370765.

15. Malcolm K.C., Worthen G.S. Lipopolysaccharide stimulates p38-dependent induction of antiviral genes in neutrophils independently of paracrine factors. J Biol Chem. 2003;278(18):15693–701. https://doi.org/10.1074/jbc.M212033200.

16. Perobelli S.M., Galvani R.G., Gonçalves-Silva T. et al. Plasticity of neutrophils reveals modulatory capacity. Braz J Med Biol Res. 2015;48(8):665–75. https://doi.org/10.1590/1414-431X20154524.

17. Yazdani H.O., Roy E., Comerci A.J. et al. Neutrophil extracellular traps drive mitochondrial homeostasis in tumors to augment growth. Cancer Res. 2019;79(21):5626–39. https://doi.org/10.1158/0008-5472.CAN-19-0800.

18. Yousefi S., Gold J., Andina N. et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med. 2008;14(9): 949–53. https://doi.org/10.1038/nm.1855.

19. Coussens L.M., Tinkle C.L., Hanahan D., Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 2000;103(3):481–90. https://doi.org/10.1016/s0092-8674(00)00139-2.

20. Mayadas T.N., Cullere X., Lowell C.A. The multifaceted functions of neutrophils. Annu Rev Pathol. 2014;9:181–218. https://doi.org/10.1146/annurev-pathol-020712-164023.

21. Al-Benna S., Shai Y., Jacobsen F., Steinstraesser L. Oncolytic activities of host defense peptides. Int J Mol Sci. 2011;12(11):8027–51. https://doi.org/10.3390/ijms12118027.

22. Cristinziano L., Luca Modestino L., Loffredo S. et al. Anaplastic thyroid cancer cells induce the release of mitochondrial extracellular DNA traps by viable neutrophils. J Immunol. 2020;204(5):1362–72. https://doi.org/10.4049/jimmunol.1900543.

23. Gupta A.K., Joshi M.B., Philippova M. et al. Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosismediated cell death. FEBS Lett. 2010;584(14):3193–7. https://doi.org/10.1016/j.febslet.2010.06.006.

24. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74. https://doi.org/10.1016/j.cell.2011.02.013.

25. Cools-Lartigue J., Spicer J., McDonald B. et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest. 2013;123(8):3446–58. https://doi.org/10.1172/JCI67484.

26. Demers M., Krause D.S., Schatzberg D. et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancerassociated thrombosis. Proc Natl Acad Sci U S A. 2012;109(32):13076– 81. https://doi.org/10.1073/pnas.1200419109.

27. Hoffmann J.H.O., Enk A.H. Neutrophil extracellular traps in dermatology: caught in the NET. J Dermatol Sci. 2016;84(1):3–10. https://doi.org/10.1016/j.jdermsci.2016.07.001.

28. Rosales C. Neutrophil: a cell with many roles in inflammation or several cell types? Front Physiol. 2018;9:113. https://doi.org/10.3389/fphys.2018.00113.

29. Kim J., Bae J.-S. Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm. 2016;2016:6058147. https://doi.org/10.1155/2016/6058147.

30. Rayes R.F. Primary tumors induce neutrophil extracellular traps with targetable metastasis promoting effects. JCI Insight. 2019;5(16):e128008. https://doi.org/10.1172/jci.insight.128008.

31. Gorudko I.V., Cherkalina O.S., Sokolov A.V. et al. New approaches to the measurement of the concentration and peroxidase activity of myeloperoxidase in human blood plasma. [Novye podhody k opredeleniyu koncentracii i peroksidaznoj aktivnosti mieloperoksidazy v plazme krovi cheloveka]. Bioorganicheskaya himiya. 2009;35(5):629–39. (In Russ.).

32. Bromberg M.E., Capello M. Cancer and blood coagulation: molecular aspects. Cancer J Sci Am. 1999;5(3):132–8.

33. Loreto M.F., De Martinis M., Corsi M.P. et al. Coagulation and cancer: implications for diagnosis and management. Pathol Oncol Res. 2000;6(4):301–12. https://doi.org/10.1007/BF03187336.

34. Panagopoulos V., Leach D.A., Zinonos I. et al. Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment. Int J Oncol. 2017;50(4):1191–200. https://doi.org/10.3892/ijo.2017.3883.

35. Andryukov B.G., Somova L.M., Drobot E.I., Matosova E.V. Defensive strategy of neutrophilic granulocytes against pathogenic bacteria. [Zashchitnye strategii nejtrofil'nyh granulocitov ot patogennyh bakterij]. Zdorov'e. Medicinskaya ekologiya. Nauka. 2017;(1):4–18. (In Russ.). https://doi.org/10.5281/zenodo.345606.

36. Uribe-Querol E., Rosales C. Neutrophils in cancer: two sides of the same coin. J Immunol Res. 2015;2015:983698. https://doi.org/10.1155/2015/983698.

37. Solopova A.G., Moskvichyova V.S., Blbulyan T.A. et al. Topical issues of prevention, diagnosis and treatment of vulvar and vaginal cancer. Obstetrics, Gynecology and Reproduction. 2018;12(4):62–70. (In Russ.). https://doi.org/10.17749/2313-7347.2018.12.4.062-070.

38. Shaul M.E., Fridlender Z.G. Cancer-related circulating and tumorassociated neutrophils – subtypes, sources and function. FEBS J. 2018;285(23):4316–42. https://doi.org/10.1111/febs.14524.

39. Merza M., Hartman H., Rahman M. et al. Neutrophil extracellular traps induce trypsin activation, Inflammation, and tissue damage in mice with severe acute pancreatitis. Gastroenterology. 2015;149(7):1920–31.e8. https://doi.org/10.1053/j.gastro.2015.08.026.

40. Metzler K.D., Fuchs T.A., Nauseef W.M. et al. Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. Blood. 2011;117(3):953–9. https://doi.org/10.1182/blood-2010-06-290171.

41. Pahler J.C., Tazzyman S., Erez N. et al. Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response. Neoplasia. 2008;10(4):329–39. https://doi.org/10.1593/neo.07871.

42. Valadez-Cosmes P., Raftopoulou S., Mihalic Z.N. et al. Myeloperoxidase: growing importance in cancer pathogenesis and potential drug target. Pharmacol Ther. 2022;236:108052. https://doi.org/10.1016/j.pharmthera.2021.108052.

43. Cai H., Chuang C.Y., Hawkins C.L., Davies M.J. Binding of myeloperoxidase to the extracellular matrix of smooth muscle cells and subsequent matrix modification. Sci Rep. 2020;10(1):666. https://doi.org/10.1038/s41598-019-57299-6.

44. Nesterova I.V., Kovaleva S.V., Fomicheva E.V. et al. Clinical and immunological parallels in neoplastic diseases of the digestive organs: clinical markers of immunodeficiency and dysfunction of the microbicidal and cytotoxic mechanisms of neutrophil granulocytes. [Klinikoimmunologicheskie paralleli pri neoplasticheskih zabolevaniyah organov pishchevareniya: klinicheskie markery immunodeficita i narusheniya funkcionirovaniya mikrobicidnyh i citotoksicheskih mekhanizmov nejtrofil'nyh granulocitov]. XIV Mezhdunarodnyj kongress po reabilitacii v medicine i immunoreabilitacii: tezisy dokladov. Izrail', 2009. 2009;11(1):79a. (In Russ.).

45. de Bont C.M., Eerden N., Boelens W.C., Pruijn G.J.M. Neutrophil proteases degrade autoepitopes of NET-associated proteins. Clin Exp Immunol. 2020;199(1):1–8. https://doi.org/10.1111/cei.13392.

46. López-Otín C., Matrisian L.M. Emerging roles of proteases in tumour suppression. Nat Rev Cancer. 2007;7(10):800–8. https://doi.org/10.1038/nrc2228.

47. Moali C., Hulmes D.J.S. Extracellular and cell surface proteases in wound healing: new players are still emerging. Eur J Dermatol. 2009;19(6):552– 64. https://doi.org/10.1684/ejd.2009.0770.

48. Sanderson R.D., Bandari S.K., Vlodavsky I. Proteases and glycosidases on the surface of exosomes: newly discovered mechanisms for extracellular remodeling. Matrix Biol. 2019;75–76:160–9. https://doi.org/10.1016/j.matbio.2017.10.007.

49. Nyberg P., Ylipalosaari M., Sorsa T., Salo T. Trypsins and their role in carcinoma growth. Exp Cell Res. 2006;312(8):1219–28. https://doi.org/10.1016/j.yexcr.2005.12.024.

50. Vilen S.-T., Nyberg P., Hukkanen M. Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma. Exp Cell Res. 2008;314(4):914–26. https://doi.org/10.1016/j.yexcr.2007.10.025.

51. Morimoto-Kamata R., Yui S. Insulin-like growth factor-1 signaling is responsible for cathepsin G-induced aggregation of breast cancer MCF-7 cells. Cancer Sci. 2017;108(8);1574–83. https://doi.org/10.1111/cas.13286.

52. Wilson T.J., Nannuru K.C., Futakuchi M. et al. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand. Cancer Res. 2008;68(14):5803–11. https://doi.org/10.1158/0008-5472.CAN-07-5889.

53. McLoed A.G., Sherrill T.P., Cheng D.-S. et al. Neutrophil-derived IL-1β impairs the efficacy of NF-κB inhibitors against lung cancer. Cell Rep. 2016;16(1):120–32. https://doi.org/10.1016/j.celrep.2016.05.085.

54. Clancy D.M., Sullivan G.P., Moran H.B.T. et al. Extracellular neutrophil proteases are efficient regulators of IL-1, IL-33, and IL-36 cytokine activity but poor effectors of microbial killing. Cell reports. 2018;22(11):2937–50. https://doi.org/10.1016/j.celrep.2018.02.062.

55. Acuff H.B., Carter K.J., Fingleton B. et al. Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Res. 2006;66(1):259–66. https://doi.org/10.1158/0008-5472.CAN-05-2502.

56. Park J.-H., Rasch M.G., Qiu J. et al. Presence of insulin-like growth factor binding proteins correlates with tumor-promoting effects of matrix metalloproteinase 9 in breast cancer. Neoplasia. 2015;17(5):421–33. https://doi.org/10.1016/j.neo.2015.04.003.

57. Peng Z., Liu C., Victor A.R. et al. Tumors exploit CXCR4hiCD62Llo aged neutrophils to facilitate metastatic spread. Oncoimmunology. 2021;10(1):1870811. https://doi.org/10.1080/2162402X.2020.1870811.

58. Yang Q., Mas A., Diamond M.P., Al-Hendy A. The mechanism and function of epigenetics in uterine leiomyoma development. Reprod Sci. 2016;23(2):163–75. https://doi.org/10.1177/1933719115584449.

59. Audia J.E., Campbell R.M. Histone modifications and cancer. Cold Spring Harb Perspect Biol. 2016;8(4):a019521. https://doi.org/10.1101/cshperspect.a019521.

60. Podaza E., Sabbione F., Risnik D. et al. Neutrophils from chronic lymphocytic leukemia patients exhibit an increased capacity to release extracellular traps (NETs). Cancer Immunol Immunother. 2017;66(1):77– 89. https://doi.org/10.1007/s00262-016-1921-7.

61. Nie M., Yang L., Bi X. et al. Neutrophil extracellular traps induced by IL8 promote diffuse large B-cell lymphoma progression via the TLR9 signaling. Clin Cancer Res. 2019;25(6):1867–79. https://doi.org/10.1158/1078-0432.CCR-18-1226.

62. Sun N., Li X., Wang Z. et al. A multiscale TiO2 nanorod array for ultrasensitive capture of circulating tumor cells. ACS Appl Mater Interfaces. 2016;8(20):12638–43. https://doi.org/10.1021/acsami.6b02178.

63. Mao Z., Zhang J., Shi Y. et al. CXCL5 promotes gastric cancer metastasis by inducing epithelial-mesenchymal transition and activating neutrophils. Oncogenesis. 2020;9(7):63. https://doi.org/10.1038/s41389-020-00249-z.

64. Teijeira A., Garasa S., Gato M. et al. CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity. Immunity. 2020;52(5):856871.e8. https://doi.org/10.1016/j.immuni.2020.03.001.

65. Tohme S., Yazdani H.O., Al-Khafaji A.B. et al. Neutrophil extracellular traps promote the development and progression of liver metastases after surgical stress. Cancer Res. 2016;76(6):1367–80. https://doi.org/10.1158/0008-5472.CAN-15-1591.

66. Fuchs T.A., Brill A., Duerschmied D. et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A. 2010;107(36):15880–5. https://doi.org/10.1073/pnas.1005743107.

67. Chaffer C.L., Weinberg R.A. A perspective on cancer cell metastasis. Science. 2011;331(6024):1559–64. https://doi.org/10.1126/science.1203543.

68. Chen Y., Hu H., Tan S. et al. The role of neutrophil extracellular traps in cancer progression, metastasis and therapy. Exp Hematol Oncol. 2022;11(1):99. https://doi.org/10.1186/s40164-022-00345-3.

69. Farrera C., Fadeel B. Macrophage clearance of neutrophil extracellular traps is a silent process. J Immunol. 2013;191(5):2647–56. https://doi.org/10.4049/jimmunol.1300436.

70. Oklu R., Sheth R.A., Wong K.H.K. et al. Neutrophil extracellular traps are increased in cancer patients but does not associate with venous thrombosis. Cardiovasc Diagns Ther. 2017;7(Suppl 3):S140–S149. https://doi.org/10.21037/cdt.2017.08.01.

71. Li Y., Yang Y., Gan T. et al. Extracellular RNAs from lung cancer cells activate epithelial cells and induce neutrophil extracellular traps. Int J Oncol. 2019;55(1):69–80. https://doi.org/10.3892/ijo.2019.4808.

72. Klebanoff S.J. Myeloperoxidase: friend and foe. J Leukoc Biol. 2005;77(5):598–625. https://doi.org/10.1189/jlb.1204697.

73. Cools-Lartigue J., Spicer J., Najmeh S., Ferri L. Neutrophil extracellular traps in cancer progression. Cell Mol Life Sci. 2014;71(21):4179–94. https://doi.org/10.1007/s00018-014-1683-3.

74. Berger-Achituv S., Brinkmann V., Abed U.A. et al. A proposed role for neutrophil extracellular traps in cancer immunoediting. Front Immunol. 2013;4:48. https://doi.org/10.3389/fimmu.2013.00048.

75. Thalin C., Lundström S., Seignez C. et al. Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer. PLoS One. 2018;13(1):e0191231. https://doi.org/10.1371/journal.pone.0191231.

76. Cedervall J., Dragomir A., Saupe F. et al. Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice. Oncoimmunology. 2017;6(8):e1320009. https://doi.org/10.1080/2162402X.2017.1320009.

77. Hisada Y., Grover S.P., Maqsood A. et al. Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumors. Haematologica. 2020;105(1):218–25. https://doi.org/10.3324/haematol.2019.217083.

78. Zhu T., Zou X., Yang C. et al. Neutrophil extracellular traps promote gastric cancer metastasis by inducing epithelial-mesenchymal transition. Int J Mol Med. 2021;48(1):127. https://doi.org/10.3892/ijmm.2021.4960.

79. Volkov D.V., Tetz G.V., Rubtsov Y.P. et al. Neutrophil extracellular traps (NETs): opportunities for targeted therapy. Acta Naturae. 2021;13(3):15– 23. https://doi.org/10.32607/actanaturae.11503.

80. Zhang Y., Chandra V., Sanchez E.R. et al. Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer. J Exp Med. 2020:217(12):e20190354. https://doi.org/10.1084/jem.20190354.

81. Schalper K.A., Carleton M., Zhou M. et al. Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors. Nat Med. 2020;26(5):688–92. https://doi.org/10.1038/s41591-020-0856-x.